See more : Kyungdong Invest Co., Ltd (012320.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Medacta Group SA (0A05.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medacta Group SA, a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- Alarum Technologies Ltd. (ALAR) Income Statement Analysis – Financial Results
- Border Petroleum Limited (BOPFF) Income Statement Analysis – Financial Results
- Lekoil Limited (LEK.L) Income Statement Analysis – Financial Results
- Gaming Realms plc (PSDMF) Income Statement Analysis – Financial Results
- AB Volvo (publ) (VOLV-B.ST) Income Statement Analysis – Financial Results
Medacta Group SA (0A05.L)
About Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 510.78M | 437.12M | 363.13M | 302.49M | 310.62M | 272.61M | 244.68M | 219.05M |
| Cost of Revenue | 162.93M | 131.87M | 101.88M | 88.24M | 86.93M | 68.63M | 62.08M | 54.50M |
| Gross Profit | 347.85M | 305.26M | 261.25M | 214.26M | 223.70M | 203.98M | 182.60M | 164.55M |
| Gross Profit Ratio | 68.10% | 69.83% | 71.94% | 70.83% | 72.02% | 74.82% | 74.63% | 75.12% |
| Research & Development | 20.32M | 16.22M | 11.31M | 6.83M | 7.64M | 3.93M | 3.48M | 3.11M |
| General & Administrative | 65.80M | 60.62M | 49.83M | 45.21M | 49.28M | 9.67M | 9.44M | 10.53M |
| Selling & Marketing | 186.67M | 159.59M | 132.56M | 110.07M | 127.09M | 104.96M | 97.44M | 85.77M |
| SG&A | 252.47M | 220.22M | 182.39M | 155.28M | 176.37M | 114.63M | 106.88M | 96.30M |
| Other Expenses | 614.00K | 0.00 | 0.00 | -1.13M | -210.00K | -705.00K | -1.03M | -1.28M |
| Operating Expenses | 273.40M | 247.15M | 202.69M | 171.42M | 206.75M | 141.77M | 131.91M | 113.78M |
| Cost & Expenses | 436.34M | 379.01M | 304.57M | 259.66M | 293.68M | 210.40M | 193.99M | 168.28M |
| Interest Income | 103.00K | 3.32M | 3.11M | 2.90M | 3.31M | 217.00K | 274.00K | 55.00K |
| Interest Expense | 6.83M | 3.66M | 3.44M | 3.04M | 3.36M | 2.10M | 1.69M | 1.19M |
| Depreciation & Amortization | 43.13M | 50.99M | 40.04M | 37.02M | 33.73M | 24.84M | 22.39M | 18.72M |
| EBITDA | 119.64M | 106.96M | 97.82M | 81.96M | 66.50M | 84.98M | 71.42M | 68.53M |
| EBITDA Ratio | 23.42% | 24.47% | 26.94% | 27.09% | 21.41% | 31.38% | 29.25% | 31.61% |
| Operating Income | 74.44M | 69.46M | 67.08M | 52.84M | 40.10M | 61.51M | 49.66M | 49.50M |
| Operating Income Ratio | 14.57% | 15.89% | 18.47% | 17.47% | 12.91% | 22.56% | 20.30% | 22.60% |
| Total Other Income/Expenses | -15.72M | -6.67M | -3.33M | -9.51M | -5.98M | -3.47M | -2.31M | -876.00K |
| Income Before Tax | 58.73M | 54.79M | 55.45M | 39.93M | 13.63M | 58.04M | 47.35M | 48.62M |
| Income Before Tax Ratio | 11.50% | 12.53% | 15.27% | 13.20% | 4.39% | 21.29% | 19.35% | 22.20% |
| Income Tax Expense | 11.36M | 8.54M | 3.93M | 2.84M | 1.77M | 12.29M | 13.85M | 9.40M |
| Net Income | 47.36M | 46.25M | 51.52M | 37.09M | 11.86M | 45.75M | 33.50M | 39.22M |
| Net Income Ratio | 9.27% | 10.58% | 14.19% | 12.26% | 3.82% | 16.78% | 13.69% | 17.90% |
| EPS | 2.37 | 2.32 | 2.58 | 1.85 | 0.59 | 2.29 | 1.67 | 1.96 |
| EPS Diluted | 2.37 | 2.31 | 2.58 | 1.85 | 0.59 | 2.29 | 1.67 | 1.96 |
| Weighted Avg Shares Out | 19.95M | 19.98M | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M |
| Weighted Avg Shares Out (Dil) | 19.95M | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M |
Source: https://incomestatements.info
Category: Stock Reports